ADHD Treatment in South Africa: Overcoming Regulatory Barriers

Attention deficit and hyperactivity disorder (ADHD) affects 5-7% of school-going children in South Africa, but doctors can only prescribe treatment for a month at a time, blocking regular medication for many children, especially those in the public sector. Methylphenidate, the gold standard for ADHD treatment, is classified as a schedule six drug, requiring a monthly prescription, creating administrative and financial difficulties for patients and caregivers. Untreated ADHD can lead to significant problems, including fractured educational journeys, unemployment, depression, addiction, and even suicide. It's time to change healthcare policies to address this issue.